Back to News
Market Impact: 0.4

Keurig Dr Pepper stock rating resumed at Overweight by Morgan Stanley

Analyst InsightsCorporate EarningsM&A & RestructuringCapital Returns (Dividends / Buybacks)Commodities & Raw Materials
Keurig Dr Pepper stock rating resumed at Overweight by Morgan Stanley

Morgan Stanley resumed coverage on Keurig Dr Pepper (KDP) with an Overweight rating and a $38.00 price target versus $31.06, implying ~22% upside. The note flags value-unlocking catalysts from the planned early-2027 separation into Beverage Co. and Global Coffee Co., alongside strong soda/energy growth and pricing. It also cites KDP’s Q2 2026 beat (adj. EPS $0.57 vs $0.54; revenue $7.31B vs $7.26B) and continued shareholder support with a 2.96% dividend yield and dividend hikes for five consecutive years.

Analysis

The cleaner read is that KDP is becoming a two-story stock: a defensive U.S. beverage asset with improving mix, and a structurally messier coffee asset whose commodity beta can cap the multiple. In the next 1-3 months, the market will likely trade the near-term earnings power of the refreshment side more than the 2027 separation, so any sustained outperformance versus KO/PEP probably comes from visible pricing and share gains in zero-sugar and energy rather than the spin narrative itself.

Second-order beneficiaries are the soda/energy ecosystem and the capital-markets story around forced simplification. If management executes, the beverage entity could be valued more like a branded growth staple, while the coffee entity could be marked at a discount until arabica normalizes; that creates a natural basis trade between the two pieces. The main loser is the “conglomerate discount” holders who want a clean catalyst now: if coffee costs stay elevated for several quarters, the sum-of-parts math can remain correct while the stock underperforms because near-term margin pressure offsets the narrative.

The contrarian risk is that the market may be overpaying for an event that is still far away and not fully under management’s control. What can reverse the move is a renewed spike in arabica, evidence that beverage growth is merely promotional, or any sign the separation timetable slips beyond early 2027. For MS, this is more an underwriting/coverage win than a direct earnings driver; the real trade is in KDP’s relative multiple versus KO and PEP, not in the bank itself.

More News